Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(60 sites)

United States

Research Site, Birmingham, Alabama

Research Site, Costa Mesa, California

Research Site, Los Angeles, California

Research Site, Orange, California

Research Site, Miami Beach, Florida